Discussing healthcare and resilience in Prague

A delegation of AmCham EU members was in Prague last week to discuss European health policy with key stakeholders in the Czech Republic. Over Tuesday, 8 November and Wednesday, 9 November, and in collaboration with AmCham Czech Republic, members brought their perspectives on issues including healthcare infrastructure, public investment, the recovery and resilience facility and the European Health Data Space. The delegation met with a range of stakeholders, including Jakub Dvořáček, MHA, LLM, Deputy Health Minister for EU Affairs, Ministry of Health of the Czech Republic. We are grateful to AmCham Czech Republic for the cooperation and partnership.

News

16 Nov 2022

Healthcare

HomePolicy and newsLibraryDiscussing healthcare and resilience in Prague

The delegation also met with:

Karel Hejduk, Director of National Screening Center, Institute of Health Information and Statistics (ÚZIS), Ministry of Health of the Czech Republic
Ondřej Májek, Ph.D. National Screening Center, Ministry of Health, MUDr
Richard Pikner, Ph.D. Councilor, Pilsen Regional Council, Health Care, Hospital Klatovy
Mgr. René Samek, MA, MSc., CzechInvest
Miloš Táborský, Ph.D., MBA, FESC, Director, National Telemedicine Center (NTMC)

Click here for more on our advocacy on the European Health Data Space.

Related items

News

20 May 2026

Healthcare, competitiveness, innovation and simplification

Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.

The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.

The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.

Healthcare

Simplification